Marketplace

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

1120 of 1618

Article ID: 717036

Quest Diagnostics Now Participating in NCI-MATCH Precision Medicine Clinical Trial

71st AACC Annual Scientific Meeting Press Program

As the leader in Advanced Diagnostics, including Next Generation Sequencing (NGS), Quest joins a select group of commercial and academic laboratories to meet the rigorous requirements for participation in this clinical trial. Both the Quest Med Fusion 50SEQ cancer panel and IBM Watson Genomics from Quest Diagnostics service fulfill the trial's criteria for accuracy and reliability in tumor profiling.

Released:
6-Aug-2019 2:05 PM EDT

Article ID: 717032

Quest Diagnostics to accelerate cardiovascular disease biomarker discovery as part of One Brave Idea™ initiative to end coronary heart disease

71st AACC Annual Scientific Meeting Press Program

The power of healthcare data gives rise to novel markers of cardiovascular disease and stroke in the earliest, preventable stages

Released:
6-Aug-2019 2:05 PM EDT

Article ID: 717028

Data Innovations Partners with STS Rules Verification Testing to Accelerate Laboratory Autoverification

71st AACC Annual Scientific Meeting Press Program

Data Innovations (DI) and STS announced a strategic partnership to deliver automated and intelligent rules verification testing for Data Innovations’ industry-leading Autoverification solution from their flagship lab enablement platform, Instrument Manager.

Released:
6-Aug-2019 2:05 PM EDT

Article ID: 717026

Lab Enablement Leadership as Data Innovations Celebrates 30th Anniversary

71st AACC Annual Scientific Meeting Press Program

Lab enablement solutions industry leader, Data Innovations, celebrates their 30th anniversary. Founded as the lab industry’s first Connectivity provider with its flagship solution, Data Innovations has continued to evolve as the clinical lab’s go-to technology platform for lab optimization, standardization, and workflow automation.

Released:
6-Aug-2019 2:05 PM EDT

Article ID: 717030

Workforce Drug Testing Positivity Climbs to Highest Rate Since 2004, According to New Quest Diagnostics Analysis

71st AACC Annual Scientific Meeting Press Program

Analysis of more than ten million workplace drug test results shows increases in marijuana positivity across nearly all employee testing categories. Increases in post-accident positivity in the general U.S. workforce outpace those for all other testing reasons, including pre-employment screening

Released:
6-Aug-2019 2:05 PM EDT

Article ID: 717018

Quest Diagnostics Welcomes New Members to the Global Diagnostics Network (GDN)

71st AACC Annual Scientific Meeting Press Program

Two new companies join the GDN, expanding this novel worldwide network of leading diagnostics service providers. With nine members spanning the globe, the GDN has a presence in countries covering two-thirds of the world's population, and over 90% of the global pharmaceutical market

Released:
6-Aug-2019 12:05 PM EDT
Newswise: Siemens Healthineers to Showcase the Power of Data in the Lab with its Atellica Diagnostics IT Solutions at AACC 2019

Article ID: 716989

Siemens Healthineers to Showcase the Power of Data in the Lab with its Atellica Diagnostics IT Solutions at AACC 2019

71st AACC Annual Scientific Meeting Press Program

At the 71st AACC Annual Scientific Meeting & Clinical Lab Expo, Siemens Healthineers will feature in Booth #1039 its innovative IT solutions to combat the laboratory’s staffing challenges, limited budgets, and the increasing complexity in sample management and testing.

Released:
6-Aug-2019 10:25 AM EDT
Newswise: Worthington Announces Release of New Product Catalog at American Association for Clinical Chemistry

Article ID: 716987

Worthington Announces Release of New Product Catalog at American Association for Clinical Chemistry

71st AACC Annual Scientific Meeting Press Program

A new digital catalog for a new generation of life science, pre-clinical and bulk OEM/bioprocessing researchers. This new catalog highlights enzymes and related biochemicals for classical and molecular diagnostics, biochemistry, bioprocessing and pre-clinical research applications.

Released:
6-Aug-2019 9:05 AM EDT
Newswise: BioIVT Acquires Keystone Biologicals, Expands its Offering of Disease-state Biospecimens

Article ID: 716983

BioIVT Acquires Keystone Biologicals, Expands its Offering of Disease-state Biospecimens

71st AACC Annual Scientific Meeting Press Program

BioIVT, a leading provider of research models and services for drug and diagnostic development, has acquired Keystone Biologicals, Inc., a supplier of disease-state plasma, sera and controls, located in Hatboro, PA.

Released:
6-Aug-2019 9:00 AM EDT

Showing results

1120 of 1618

Chat now!